Clinical Trials Directory

Trials / Completed

CompletedNCT04699526

Evaluation of Universal Prevention Curriculum for Schools in Peru

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
27,012 (actual)
Sponsor
HBSA · Academic / Other
Sex
All
Age
11 Years – 19 Years
Healthy volunteers
Accepted

Summary

This randomized controlled trial was conducted to evaluate a universal prevention curriculum (UPC) training for Peruvian school administrators and teachers to reduce substance use among students. Twenty-eight schools were randomly assigned to intervention and control conditions (14 per condition). Substance use outcomes were assessed with repeated cross-sectional samples of students in 2018 and 2019. Multi-level analyses were conducted to assess intervention effects on students' substance use and related problems.

Detailed description

This randomized controlled trial was conducted to evaluate a universal prevention curriculum (UPC) training for Peruvian school administrators and teachers to reduce substance use among students. Twenty-eight schools were randomly assigned to intervention and control conditions (14 per condition). Prevention leadership action teams were formed at intervention schools to implement evidence-based school policies and positive school climate activities, and a classroom substance use prevention curriculum. Substance use outcomes were assessed with repeated cross-sectional samples of students in 2018 and 2019. Multi-level analyses were conducted to assess intervention effects on students' substance use and related problems.

Conditions

Interventions

TypeNameDescription
OTHERUniversal Prevention Curriculum Training for SchoolsSchool administrators and teachers participated in UPC training and formed prevention leadership action teams

Timeline

Start date
2018-05-01
Primary completion
2019-11-30
Completion
2019-11-30
First posted
2021-01-07
Last updated
2021-01-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04699526. Inclusion in this directory is not an endorsement.